Invesco’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,104
Closed -$51K 4006
2021
Q1
$51K Buy
+10,104
New +$58.8K ﹤0.01% 3826
2019
Q1
Sell
-10,247
Closed -$84K 3774
2018
Q4
$84K Sell
10,247
-336
-3% -$3.35K ﹤0.01% 3667
2018
Q3
$132K Sell
10,583
-2,451
-19% -$24.6K ﹤0.01% 3757
2018
Q2
$104K Buy
+13,034
New +$135K ﹤0.01% 3772
2017
Q2
Sell
-14,484
Closed -$87K 3711
2017
Q1
$87K Buy
14,484
+1,804
+14% +$10.9K ﹤0.01% 3656
2016
Q4
$76K Buy
12,680
+538
+4% +$3.79K ﹤0.01% 3623
2016
Q3
$91K Buy
12,142
+79
+0.7% +$532 ﹤0.01% 3595
2016
Q2
$91K Buy
+12,063
New +$87.2K ﹤0.01% 3629

Other funds holding MNOV

Invesco's MNOV Position: Q2 2021 in Review

Invesco sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 10,104 shares — an estimated $51K sold.

Invesco first reported a position in MNOV in Q2 2016 and held it in 8 quarters. The position peaked at $132K in Q3 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

  • Invesco reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 10,104 MediciNova shares in Q2 2021, an estimated $51K.
  • Invesco first reported a position in MediciNova in Q2 2016 and held it in 8 quarters.
  • Invesco's MediciNova position peaked at $132K in Q3 2018.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.